A batch of Oncaspar for providing emergency medical care to children with acute lymphoblastic leukemia has arrived in Russia, Moscow Endocrine Plant reports.
“Onkaspar (INN pegaspargase) is under patent protection and is not registrered in Russia, so the government instructed FSUE “Moscow Endocrine Plant”(under the Ministry of Industry and Trade of Russia) to organize the purchase, import and delivery of 1970 packages of Onkaspar”, the report says.
“The first batch of Onkaspar will go to 70 medical organizations in Russia. The prompt cooperation between the Government and executive authorities and the experience accumulated by Moscow Endocrine Plant have made it possible to provide the necessary medical care to our children in a timely manner. The import of the remaining 575 packages of Onkaspar to the Russian Federation is scheduled for August this year,” said Denis Manturov, Minister of Industry and Trade of Russia.
Less than a month after the decree of the government of the Russian Federation, Moscow Endocrine Plant imported the first batch of 1,395 packages of the vital drug.